Opus Genetics, Inc. (($IRD)) announced an update on their ongoing clinical study. Opus Genetics, Inc. is conducting a clinical study titled ‘An ...
Abstract: Threats that have been primarily targeting nation states and their associated entities have expanded the target zone to include the private and corporate sectors. This class of threats, well ...